You have 9 free searches left this month | for more free features.

Stage III (unresectable)

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Carcinoma in the Adrenal Cortex, Stage III Adrenal Cortex Carcinoma AJCC v8, Stage IV Adrenal Cortex Carcinoma AJCC

Active, not recruiting
  • Metastatic Carcinoma in the Adrenal Cortex
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 12, 2022

NSCLC (NSCLC) Trial in Worldwide (Durvalumab)

Active, not recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • Gainesville, Georgia
  • +27 more
Dec 20, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous

Active, not recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +20 more
  • Ipilimumab
  • +3 more
  • Tampa, Florida
  • +6 more
Jan 13, 2023

Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIB Hepatocellular Carcinoma

Completed
  • Stage III Hepatocellular Carcinoma AJCC v8
  • +6 more
  • Yttrium Y 90 Glass Microspheres
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

NSCLC Stage III Trial in Hefei (Envafolimab)

Not yet recruiting
  • Non-small Cell Lung Cancer Stage III
  • Hefei, Anhui, China
    Anhui Provincial Cancer Hospital
Jun 8, 2022

Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III Trial in Tampa (Genomically

Recruiting
  • Nonsmall Cell Lung Cancer
  • +3 more
  • Genomically Guided Radiation Therapy (RT)
  • Tampa, Florida
    Moffitt Cancer Center
May 23, 2023

NSCLC Stage III, EGFR Positive NSCLC, Non-squamous Non-small-cell Lung Cancer Trial in Korea, Republic of (Lazertinib)

Recruiting
  • Non-small Cell Lung Cancer Stage III
  • +2 more
  • Busan, Korea, Republic of
  • +12 more
Jan 17, 2023

Colorectal Adenocarcinoma, Gastric Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Atlanta (Nanoliposomal

Recruiting
  • Colorectal Adenocarcinoma
  • +13 more
  • Nanoliposomal Irinotecan
  • Trifluridine and Tipiracil Hydrochloride
  • Atlanta, Georgia
  • +2 more
Jan 6, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in

Not yet recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +4 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Feb 28, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous

Not yet recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +12 more
  • Biopsy
  • +8 more
  • (no location specified)
Jun 8, 2023

CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes

Recruiting
  • Unresectable /Inoperable Locally Advanced (Stage II-III) Non-small Cells Lung Cancer (NSCLC)
    • Grozny, Russian Federation
    • +4 more
    May 31, 2023

    NSCLC Trial in Worldwide (Alectinib, Entrectinib, Pralsetinib)

    Recruiting
    • Non-Small Cell Lung Cancer
    • San José, Costa Rica
    • +3 more
    Aug 4, 2022

    NSCLC, Stage III Trial in Chengdu (GFH018, Toripalimab, Paclitaxel)

    Not yet recruiting
    • NSCLC, Stage III
    • Chengdu, Sichuan, China
      West China Hospital, Sichuan University
    May 23, 2022

    Stage III Non-small-cell Lung Cancer Trial in Foshan, Guangzhou (other, radiation, drug)

    Recruiting
    • Stage III Non-small-cell Lung Cancer
    • Neoadjuvant therapy
    • +4 more
    • Foshan, Guangdong, China
    • +2 more
    Oct 25, 2022

    Metastatic Melanoma Trial in Boston (Tremelimumab, MEDI3617)

    Active, not recruiting
    • Metastatic Melanoma
    • Boston, Massachusetts
    • +1 more
    Mar 22, 2022

    Metastatic Malignant Tumor in the Brain, Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7 Trial in Houston (drug,

    Active, not recruiting
    • Metastatic Malignant Neoplasm in the Brain
    • +7 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 15, 2022

    Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in

    Active, not recruiting
    • Stage III Cutaneous Melanoma AJCC v7
    • +4 more
    • Cryosurgery
    • +3 more
    • Rochester, Minnesota
      Mayo Clinic
    Jan 3, 2023

    Metastatic Penile Squamous Cell Carcinoma, Stage III Penile Cancer AJCC v8, Stage IV Penile Cancer AJCC v8 Trial in Phoenix,

    Not yet recruiting
    • Metastatic Penile Squamous Cell Carcinoma
    • +3 more
    • Enfortumab Vedotin
    • Phoenix, Arizona
    • +2 more
    Oct 23, 2023

    NSCLC Trial in Jinan (Anlotinib HCl capsule Combined With Concurrent Chemoradiotherapy)

    Terminated
    • Non-small Cell Lung Cancer
    • Anlotinib hydrochloride capsule Combined With Concurrent Chemoradiotherapy
    • Jinan, Shandong, China
      Shandong Cancer Hospital
    Feb 9, 2022

    Stage III NSCLC, Locally Advanced, Unresectable Trial (standard Radiotherapy, Chemotherapy, Immunotherapy)

    Not yet recruiting
    • Stage III Non-small Cell Lung Cancer
    • +2 more
    • standard Radiotherapy
    • +3 more
    • (no location specified)
    Oct 20, 2023

    Lung Cancer, Stage III Lung Cancer, Unresectable Lung Carcinoma Trial in Barcelona (procedure, diagnostic test, drug)

    Recruiting
    • Lung Cancer
    • +2 more
    • Sample collection
    • +3 more
    • Barcelona, Spain
      Parc de Salut Mar - Hospital del Mar
    Dec 8, 2022

    Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

    Not yet recruiting
    • Locally Advanced Bladder Urothelial Carcinoma
    • +31 more
    • Diagnostic Laboratory Biomarker Analysis
    • Nivolumab
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Advanced Pancreatic Carcinoma, Locally Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Trial in Rochester

    Recruiting
    • Advanced Pancreatic Carcinoma
    • +9 more
    • Endoscopic Ultrasound
    • +4 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Dec 13, 2022

    Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in

    Recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • +3 more
    • Ipilimumab
    • Nivolumab
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    May 6, 2022

    Melanoma Trial in Los Angeles, Boston, New York (Ipilimumab, Nivolumab, Tocilizumab)

    Recruiting
    • Melanoma
    • Los Angeles, California
    • +3 more
    Mar 29, 2022